FirmsKentucky
7 recordsInvestor / VC
Poplar Ventures
● Louisville, KY
Louisville-based venture capital firm focused on cloud-based B2B software; backed Louisville logistics-software company SkuVault through its exit via acquisition by Linnworks.
Seed
Render Capital
● Louisville, KY
Louisville-based early-stage investment fund launched via a 2020 federal Build to Scale Capital Challenge award (in partnership with Access Ventures), providing first-risk capital to Kentucky startups in advanced manufacturing, food & beverage and logistics; led Louisville Vegan Jerky to its 2025 acquisition.
Investor / VC
Chrysalis Ventures
● Louisville, KY
Venture capital firm founded in 1993 and headquartered in Louisville, managing roughly $400 million and investing in over 65 technology and healthcare companies across the Midwest since inception; also has offices in Cleveland, Pittsburgh, Ann Arbor and Houston.
Investor / VC
Access Ventures
● Louisville, KY
Louisville-based impact investment and philanthropic organization founded in 2013, deploying blended capital (loans, grants, equity) into creative arts, innovative finance, real estate and technology-for-good ventures, including launching the Render Capital fund.
Seed
Bluegrass Angels
● Lexington, KY
Volunteer-led angel investing group founded in 2004 and based in Lexington, one of Kentucky's most active angel networks with $20M+ raised and investments in 50+ Kentucky companies across healthcare, agriculture, biotech and fintech.
Seed
Enterprise Angels
● Louisville, KY
Formal group of 40+ angel investors based in Louisville who provide seed capital and management guidance to Kentucky startups, drawing members from technology, healthcare, manufacturing, distribution and food & beverage backgrounds.
Pre-Seed
Keyhorse Capital
● Louisville, KY
Kentucky-focused pre-seed to seed venture fund with offices in Louisville, Lexington and Covington; the only Kentucky fund of its kind requiring portfolio companies to relocate to the state, with investments including a $5M round in Gravity Diagnostics in 2025.